ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) Shares Up 0.9% – Here’s Why

Posted by Lindsey Winhoffer on Dec 6th, 2025

ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Get Free Report)’s stock price rose 0.9% during trading on Friday . The stock traded as high as $9.50 and last traded at $9.46. Approximately 6,407 shares traded hands during mid-day trading, a decline of 47% from the average daily volume of 11,984 shares. The stock had previously closed at $9.38.

ProShares UltraShort Nasdaq Biotechnology Stock Up 0.9%

The stock has a 50 day simple moving average of $10.96 and a two-hundred day simple moving average of $14.22.

ProShares UltraShort Nasdaq Biotechnology Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Wednesday, September 24th were given a dividend of $0.1543 per share. This is a boost from ProShares UltraShort Nasdaq Biotechnology’s previous quarterly dividend of $0.11. The ex-dividend date of this dividend was Wednesday, September 24th. This represents a $0.62 annualized dividend and a dividend yield of 6.5%.

Hedge Funds Weigh In On ProShares UltraShort Nasdaq Biotechnology

An institutional investor recently bought a new position in ProShares UltraShort Nasdaq Biotechnology stock. Csenge Advisory Group acquired a new position in shares of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 12,421 shares of the company’s stock, valued at approximately $163,000. Csenge Advisory Group owned approximately 6.54% of ProShares UltraShort Nasdaq Biotechnology at the end of the most recent quarter.

ProShares UltraShort Nasdaq Biotechnology Company Profile

(Get Free Report)

ProShares Ultra Nasdaq Biotechnology (the Fund) seeks investment results for a single day only, not for longer periods. The Fund seeks daily investment results, before fees and expenses, that correspond to twice (200%) the daily performance of the Index. The return of the Fund for a period longer than a single trading day will be the result of each day’s returns compounded over the period, which will very likely differ from twice (200%) the return of the Nasdaq Biotechnology Index (the Index) for that period.